FDA
label_change
· 2021-09-20
FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for fluvoxamine maleate submitted by ANI Pharmaceuticals, resulting in changes to the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)